New eye scan could replace dye tests for Diabetes-Related vision loss
NCT ID NCT03922932
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a new type of eye scan called OCT angiography (OCTA) to see if it can better measure damage from diabetic retinopathy, a leading cause of vision loss. Researchers will compare OCTA images to standard dye-based tests in 290 people with diabetes. The goal is to find a safer, faster, and more objective way to diagnose and monitor the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a safer, faster, and more objective way to diagnose and monitor diabetic retinopathy, replacing dye-based tests.
- What could go wrong
- This is an observational study, not a treatment trial. The new imaging method may not prove better than current techniques, and results may not change clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI eye doctor: could software catch diabetic blindness sooner?
- Can eye scans reveal hidden clues about diabetes damage?
- AI could predict which eye treatments work best for Diabetes-Related vision loss
- New eye drug aims to restore vision in Diabetes-Related swelling
- New eye drug aims to restore vision in Diabetes-Related swelling
- Eye scans could spot Diabetes-Related vision damage years early